NVCR
Price
$16.20
Change
-$0.05 (-0.31%)
Updated
Sep 24 closing price
Capitalization
1.89B
27 days until earnings call
Intraday BUY SELL Signals
TWST
Price
$184.03
Change
+$25.53 (+16.11%)
Updated
Sep 24 closing price
Capitalization
10.51B
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NVCR vs TWST

NVCR vs TWST Comparison Chart in %
View a ticker or compare two or three
VS
NVCR vs. TWST commentary
Sep 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVCR is a Buy and TWST is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
NVCR vs TWST: Fundamental Ratings
NVCR
TWST
OUTLOOK RATING
1..100
7333
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
66
Overvalued
PROFIT vs RISK RATING
1..100
10062
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
4134
P/E GROWTH RATING
1..100
6100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TWST's Valuation (66) in the Biotechnology industry is somewhat better than the same rating for NVCR (100) in the Medical Specialties industry. This means that TWST’s stock grew somewhat faster than NVCR’s over the last 12 months.

TWST's Profit vs Risk Rating (62) in the Biotechnology industry is somewhat better than the same rating for NVCR (100) in the Medical Specialties industry. This means that TWST’s stock grew somewhat faster than NVCR’s over the last 12 months.

TWST's SMR Rating (97) in the Biotechnology industry is in the same range as NVCR (98) in the Medical Specialties industry. This means that TWST’s stock grew similarly to NVCR’s over the last 12 months.

TWST's Price Growth Rating (34) in the Biotechnology industry is in the same range as NVCR (41) in the Medical Specialties industry. This means that TWST’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's P/E Growth Rating (6) in the Medical Specialties industry is significantly better than the same rating for TWST (100) in the Biotechnology industry. This means that NVCR’s stock grew significantly faster than TWST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVCRTWST
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
77%
COMPARISON
Comparison
Sep 25, 2026
Stock price -- (NVCR: $16.20 vs. TWST: $184.03)
Brand notoriety: NVCR and TWST are both not notable
NVCR represents the Medical/Nursing Services, while TWST is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVCR: 95% vs. TWST: 199%
Market capitalization -- NVCR: $1.89B vs. TWST: $10.51B
NVCR [@Medical/Nursing Services] is valued at $1.89B. TWST’s [@Biotechnology] market capitalization is $10.51B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $179.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.87B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.56B. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVCR’s FA Score shows that 1 FA rating(s) are green while TWST’s FA Score has 0 green FA rating(s).

  • NVCR’s FA Score: 1 green, 4 red.
  • TWST’s FA Score: 0 green, 5 red.
According to our system of comparison, NVCR is a better buy in the long-term than TWST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVCR’s TA Score shows that 5 TA indicator(s) are bullish while TWST’s TA Score has 4 bullish TA indicator(s).

  • NVCR’s TA Score: 5 bullish, 4 bearish.
  • TWST’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NVCR is a better buy in the short-term than TWST.

Price Growth

NVCR (@Medical/Nursing Services) experienced а -3.11% price change this week, while TWST (@Biotechnology) price change was +18.30% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.34%. For the same industry, the average monthly price growth was -8.95%, and the average quarterly price growth was +2.02%.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.44%. For the same industry, the average monthly price growth was -12.65%, and the average quarterly price growth was +6.78%.

Reported Earning Dates

NVCR is expected to report earnings on Oct 22, 2026.

TWST is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.34% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Biotechnology (-3.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
NVCR
Daily Signal:
Gain/Loss:
TWST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ALIL30.360.02
+0.06%
Argent Focused Small Cap ETF (ALIL)
SMMU49.53-0.06
-0.12%
PIMCO Short Term Municipal Bond Active ETF (SMMU)
AVMA72.18-0.13
-0.18%
Avantis Moderate Allocation ETF (AVMA)
NCA8.27-0.19
-2.25%
Nuveen California Municipal Value Fund
KBDU10.73-0.39
-3.48%
KraneShares 2x Long BIDU Daily ETF (KBDU)

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with BLFS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then BLFS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
-0.31%
BLFS - NVCR
39%
Loosely correlated
+2.23%
ALGN - NVCR
38%
Loosely correlated
-1.72%
AZTA - NVCR
38%
Loosely correlated
+0.32%
TWST - NVCR
37%
Loosely correlated
+16.11%
A - NVCR
35%
Loosely correlated
+4.55%
More